We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




First Lung Cancer Patients Treated Using MRI-Guided Radiotherapy

By HospiMedica International staff writers
Posted on 19 Feb 2014
One of the first treatments of stereotactic body radiation therapy (SBRT) for lung cancer patients is being used with a new magnetic resonance imaging (MRI)-guided radiotherapy system.

MRI-guided radiation therapy enables clinicians to see a patient’s internal anatomy in real-time and keep the radiation beams on the target when the tumor moves during treatment. More...
SBRT is a type of radiation therapy in which a few very high doses of radiation are delivered to small, well-defined tumors to kill cancer cells while minimizing exposure to neighboring healthy organs.

The ViewRay (Cleveland, OH, USA) system, the world’s first MRI-guided radiation therapy system, is being used to treat patients at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis (MO, USA). The ViewRay system provides a patented combination of simultaneous radiation therapy delivery and continuous MRI scanning for the treatment of cancer.

“Treating patients is a key milestone for ViewRay, but more importantly, it marks a significant advance in cancer care,” said Chris A. Raanes, ViewRay president and CEO. “MRI-guided radiation therapy is no longer a research quest; today, it has become real and offers physicians a new and powerful weapon for treating cancer.”

An international institution focused on cancer treatment and research, the Siteman Cancer Center has a long history of adopting and helping to develop new technology with a focus on improving patient care and outcomes. “Real-time MR guidance offers a way to treat tumors that move with respiration,” said Jeffrey Bradley, MD, a professor of radiation oncology at Siteman Cancer Center and Washington University School of Medicine. “Our physicians and physicists report the ability to see tumors move in real-time during the entire treatment. This helps to ensure that tumor targets are hit and healthy tissue is spared.”

ViewRay is a medical device company that develops sophisticated radiation therapy technology for the treatment of cancer. The ViewRay system provides continuous soft-tissue imaging during radiation therapy using MRI-guidance, so that clinicians are able to see exactly where the radiation dose is being delivered and adapt to changes in the patient’s anatomy.

The Siteman Cancer Center is the only US National Cancer Institute designated Comprehensive Cancer Center in the state Missouri.

Related Links:

ViewRay
Washington University School of Medicine in St. Louis



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
Gold Member
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image

Explainable AI Tool Improves Brain Disorder Screening from 4D fMRI

Functional magnetic resonance imaging (fMRI) captures changes in brain activity over time, but the resulting image sequences can be difficult to analyze. Screening for brain disorders requires assessing... Read more

Critical Care

view channel
Image: Liposomes have long been used for gradual drug delivery, with their composition controlling release speed, potency, duration, and potential toxicity. (Image Credit: iStock)

New Drug Delivery System Extends Release of Local Anesthetic for Weeks

Local anesthetics used for nerve blocks often provide pain relief for only a limited period, while perioperative pain can persist much longer. Extending the duration of a nerve block therefore requires... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.